Ketamine Side Effects When You're Treating Depression
What ketamine side effects actually look like when you're being treated for depression — IV vs nasal spray, how long each lasts, and when to call your clinic. If you're weighing ketamine for depression, the real question isn't whether side effects happen — it's which ones, how strong they feel, and how long they last. Most guides describe ketamine side effects in general terms, lumping together surgical anesthesia, recreational misuse, and mental health care. This guide stays narrow on purpose: what mood-disorder patients in the Boise and Eagle area actually experience, route by route, hour by hour. Quick Answer: What Side Effects Should Depression Patients Expect From Ketamine? In a monitored clinic, the most commonly reported ketamine side effects during depression treatment are dissociation (a temporary feeling of detachment from your body or surroundings), dizziness, nausea, sedation, and a short-lived rise in blood pressure. These are listed adverse reactions in the FDA prescribing information for esketamine nasal spray , the FDA-approved form of this treatment, and they are the same families of effects described in the clinical literature on ketamine . Nearly all of them fade during the monitored recovery window. That label requires patients to be observed for at least two hours after dosing. TL;DR Most acute effects are tied to the session itself , not the days after it. See the hour-by-hour breakdown IV and nasal spray share the same side effect families but differ in delivery, extras like bad taste, and monitoring rules. Compare the two routes side by side Depression patients have specific concerns other guides skip, including anxiety during the dissociative window. Read why an unpleasant session isn't a failed one Bladder and memory concerns come mainly from frequent high-dose misuse , not supervised protocols. Review what the long-term literature describes Some symptoms warrant a same-day call. Check the red-flag list before your first session In This Article Why Do Side Effects Look Different When Ketamine Treats Depression? What Are the Most Common Short-Term Side Effects? How Long Do Ketamine Side Effects Last After a Session? IV Infusion vs. Nasal Spray: How Do Side Effects Compare? Can Ketamine Make Depression or Anxiety Feel Worse First? What About Long-Term Risks Like Bladder or Memory Problems? How Do Clinics in Boise and Eagle Reduce These Side Effects? Why Do Side Effects Look Different When Ketamine Treats Depression? Depression protocols use far smaller doses than surgery does, so the side effect picture is dominated by brief perceptual and cardiovascular changes rather than deep sedation. Sub-anesthetic dosing refers to giving ketamine at a fraction of the amount used to produce surgical anesthesia. Clinical references describe mental health infusion protocols around 0.5 mg/kg delivered slowly over roughly 40 minutes, well below anesthetic induction ranges described in the ketamine clinical monograph on NCBI Bookshelf . You stay awake, you can talk, and you can tell staff how you feel. That matters because most alarming descriptions of ketamine online come from two very different contexts: emergency anesthesia and recreational misuse. Neither reflects a quiet treatment room with a blood pressure cuff and a nurse watching the monitor. Dose isn't the only variable. Chronic pain protocols are often slower and longer than mood protocols, which changes what patients notice. The way the medication acts on glutamate signaling is covered in more depth in our explainer on how ketamine acts on the brain . For depression specifically, the FDA approved esketamine nasal spray in 2019 with a structured set of safety requirements attached, including in-clinic administration and post-dose observation, as stated in its prescribing information . Those rules exist precisely because the predictable side effects occur in a known window. Key takeaway: Mental health dosing is a fraction of anesthetic dosing, which is why the side effects are short, monitored, and mostly confined to the session itself. What Are the Most Common Short-Term Side Effects? The short list: dissociation, dizziness, nausea, sedation or drowsiness, elevated blood pressure, headache, and blurred vision. These appear among the adverse reactions described in the FDA esketamine label and in the published clinical overview of ketamine . Dissociation is a temporary sense of distance from your body, your thoughts, or the room — often described as floating, drifting, or watching yourself from slightly outside. It's expected at these doses, it's monitored, and it eases as the medication clears. Side effect When it usually shows up How long it typically lasts How clinics commonly manage it Dissociation Early in the dosing window Through the session, easing in recovery Dim lighting, quiet room, reassurance, staff present Dizziness / unsteadiness During dosing Often into the recovery period Stay reclined; assisted walking before discharge Nausea During or shortly after dosing Usually resolves the same day Anti-nausea medication, often given before dosing Blood pressure rise During dosing Typically transient Repeated vital-sign checks throughout Headache During or after the session Often same-day Hydration; discuss any pain reliever with your provider Blurred vision During dosing Eases as medication clears No driving; wait until vision is clear before discharge Two practical points patients rarely read in advance. First, nausea is easier to prevent than to treat , which is why pre-medication is a standard part of many protocols. Second, blood pressure changes are the reason monitoring is non-negotiable — the esketamine label directs providers to assess blood pressure before dosing and after administration. The label also lists contraindications, including aneurysmal vascular disease and a history of intracerebral hemorrhage. That's a screening conversation, not a surprise on treatment day. Side effects also differ by condition being treated. Our timeline guide covers what lasts minutes versus months across different protocols. ⚠️ Anything that persists well past your session — ongoing vomiting, chest pain, or blood pressure that stays high at home — is a call to your clinic, not something to wait out. How Long Do Ketamine Side Effects Last After a Session? Most acute effects are tied to the dosing window and the monitored recovery that follows. Thinking in three windows helps, and our deeper guide on what lasts minutes versus months expands on each one. During the session. Dissociation, dizziness, and altered perception are strongest while the medication is being delivered. Staff track vitals and stay with you. The recovery window. Effects taper here. The esketamine label requires observation for at least two hours after dosing before a patient is released, which gives a useful benchmark for how long clinics expect noticeable effects to persist. Same evening and next morning. Grogginess, a wobbly feeling, or tiredness can linger to bedtime for some people. Next-day effects should be minimal. If they aren't, tell your provider — that's data they use to adjust your protocol. One rule applies across both routes: arrange a ride and do not drive . The esketamine prescribing information instructs patients not to drive or operate machinery until the next day following a restful sleep. How long do ketamine side effects last for you specifically? That depends on dose, route, sleep, hydration, and whether you ate beforehand. Keeping notes makes patterns visible — we built a simple at-home tracking checklist for exactly that. IV Infusion vs. Nasal Spray: How Do Side Effects Compare? Both routes produce the same side effect families. What differs is delivery, the extras unique to nasal dosing, and the monitoring rules attached. Esketamine is the S-enantiomer of ketamine — one mirror-image half of the molecule — marketed as Spravato and FDA-approved in 2019 for treatment-resistant depression in adults, per its prescribing information . That label reports a mean absolute bioavailability of roughly 48% for the nasal route. Intravenous delivery, by definition, puts the full dose into the bloodstream. Factor IV ketamine infusion Esketamine nasal spray FDA status for depression Used off-label FDA-approved in 2019 for treatment-resistant depression Delivery Slow infusion through an IV line Self-administered nasal spray under supervision Bioavailability Full dose enters the bloodstream Label reports mean absolute bioavailability ~48% Common route-specific extras IV site discomfort or bruising Bad taste, nasal irritation, nasal discomfort Monitoring required Continuous vitals and staff present Label requires observation for at least 2 hours post-dose Driving Ride required Label: no driving until the next day after restful sleep Ketamine nasal spray side effects include the shared list — dissociation, dizziness, nausea, sedation, blood pressure elevation — plus taste and nasal irritation that IV patients don't encounter. Ketamine infusion side effects skip the nasal issues but add the small realities of an IV line. Insurance is often the deciding factor rather than tolerability, since esketamine's FDA approval opens coverage pathways that off-label infusions generally don't have. For a closer look at the approved option, see esketamine's full benefit and side effect picture . Key takeaway: Choose between routes on candidacy, coverage, and clinical fit — not on the assumption that one route is inherently gentler. Can Ketamine Make Depression or Anxiety Feel Worse First? Some people do feel worse before they feel steadier. Anxiety during the dissociative window is common enough that clinics plan for it, and the esketamine label lists anxiety among reported adverse reactions. Two experiences get confused with each other, and the distinction matters: An unpleasant session — feeling anxious, tearful, or disoriented while the medication is active, then returning to baseline during recovery. A true adverse event — symptoms that persist, escalate, or involve physical warning signs like chest pain or ongoing vomiting. Patients also describe mood that dips between sessions as the effects of a given dose fade. This is part of why protocols are built as a series with scheduled follow-up, rather than as one-off appointments. Your provider uses your reports between sessions to adjust timing. What you can do about it is concrete: Tell your clinician before dosing if anxiety is your dominant symptom, so the room and your support plan can be set up accordingly. Bring someone you trust for the ride home. Write down how the days between sessions feel, not just the session itself. Keep your existing mental health care in place unless your prescriber directs otherwise. ⚠️ Any worsening of suicidal thoughts requires same-day contact with your provider. In the US, call or text 988 for the Suicide and Crisis Lifeline, or go to the nearest emergency department. Depression remains a serious medical condition; background on it is available from the National Institute of Mental Health . If standard medications haven't worked for you, our guide on ketamine therapy for depression when nothing else worked covers how candidacy is assessed. What About Long-Term Risks Like Bladder or Memory Problems? The bladder and cognitive concerns you read about come overwhelmingly from the literature on frequent, high-dose recreational use — not from supervised depression protocols. Ketamine-associated urinary tract toxicity refers to bladder inflammation and urinary symptoms documented in people using ketamine heavily and repeatedly outside medical care; urinary and bladder effects are among the adverse effects described in the ketamine clinical monograph . Frequency and cumulative dose are the variables that separate those reports from a scheduled clinic series. That doesn't mean the topic is irrelevant to patients. It means it belongs in your monitoring plan, especially i